Factors influencing plateau timing include dose level, adherence consistency, dietary quality, exercise habits, sleep patterns, stress levels, and underlying metabolic health
The Boston Scientific/Guidant outcome establishes that patent due diligence and product liability diligence must be integrated, not siloed
Finally, we also sought to demonstrate the cardioprotective effect of 2-AB in vivo (Fig
MariTide delivered strong efficacy, including sustained weight loss without a plateau in the 52-week Phase 2 study and meaningful improvements in cardiometabolic risk factors, representing a defining advance for the obesity field, said Jay Bradner, executive vice president of research and development at Amgen, in a statement from the company